Global /Germany /Healthcare /Medical Devices /NNNN

Anbio Biotechnology

NNNN

• NASDAQ: NNNN • Delayed

27.43USD -1.4%

As of 8 June 2026, Anbio Biotechnology has a market cap of $1.2B USD, ranking #9671 globally and #136 in Germany. It ranks #847 in the Healthcare sector, and #172 in the Medical Devices industry.

Global Rank

9671

Country Rank

136

Sector Rank

847

Industry Rank

172

Key Stats

Market Cap

$1.2BUSD

Enterprise Value

$1.2BUSD

Revenue (TTM)

$8.65MUSD

Net Income (TTM)

$6.4MUSD

Profit Margin

74%

PE Ratio

189.7

PS Ratio

140.0

PB Ratio

40.5

Company Profile

Country (HQ)

Germany

Sector

Healthcare

Industry

Medical Devices

CEO

Michael Lau open_in_new

Employees

Founded

2021

IPO

19 Feb 2025

Website

anbio.com open_in_new

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.4%	1.6%	15%	43%	18%	-8.2%	329%	337%	337%

News

NNNN Analyst Forecasts

Markets

Exchange	Ticker	Price	Quotes
NASDAQ MIC: XNAS PRIMARY	NNNN Anbio Biotechnology Class A ISIN: KYG0367B1059 Shares Out.: Shares Outstanding: 43.891M¹ Shares Float: 39.691M² TV: TradingView: NASDAQ: NNNN SA: Stock Analysis: NASDAQ: NNNN YF: Yahoo Finance: NNNN GF: Google Finance: NASDAQ: NNNN NQ: NASDAQ: NNNN BA: Barron's: NNNN MS: Morningstar: XNAS: NNNN	27.43 USD	TV: TradingView: NASDAQ: NNNN SA: Stock Analysis: NASDAQ: NNNN YF: Yahoo Finance: NNNN GF: Google Finance: NASDAQ: NNNN NQ: NASDAQ: NNNN BA: Barron's: NNNN MS: Morningstar: XNAS: NNNN

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Anbio Biotechnology

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.

Similar Companies

Industry: Medical Devices (Germany)

Name	Market Cap (USD) diff.	PE	Country
Siemens Healthineers AG XETRA: SHL	$45.33B 39.34B EUR 4K%	18.7	Germany
Sartorius Aktiengesellschaft XETRA: SRT	$15.25B 13.24B EUR 1K%	81.4	Germany
Fielmann Group AG XETRA: FIE	$4.27B 3.71B EUR 255%	20.3	Germany
Ottobock SE & Co. KGaA XETRA: OBCK	$4.25B 3.69B EUR 253%	40.1	Germany
Carl Zeiss Meditec AG XETRA: AFX	$2.6B 2.25B EUR 116%	18.4	Germany
SCHOTT Pharma AG & Co. KGaA XETRA: 1SXP	$2.58B 2.24B EUR 114%	15.0	Germany

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 14K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 13K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 13K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 10K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 10K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 8K%	22.2	Ireland

chevron_leftBack